IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Mobilization of Peripheral Blood Stem Cells Using Regimen Combining Docetaxel with Granulocyte Colony-stimulating Factor in Breast Cancer Patients
Yu, Jing1; Ren, Jun1; Di, Li-jun1; Song, Guo-hong1; Zhu, Yu-lin1; Zhang, Jie1; Liang, Xu1; Che, Li1; Jiang, Han-fang1; Jia, Jun1; Zhang, Chun-rong2
关键词Docetaxel Granulocyte colony-stimulating factor (G-CSF) Mobilization Stem cell
刊名CHINESE JOURNAL OF CANCER RESEARCH
2011-03-01
DOI10.1007/s11670-011-0049-8
23期:1页:49-53
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]HEMATOPOIETIC PROGENITOR CELLS ; PHASE-III TRIAL ; G-CSF ; ADJUVANT CHEMOTHERAPY ; DOSE CHEMOTHERAPY ; RANDOMIZED-TRIAL ; COLLECTION ; PACLITAXEL ; SURVIVAL ; SUPPORT
英文摘要

Objective: To evaluate the effectiveness and safety of the mobilization of peripheral blood hematopoietic stem cells by combining docetaxel with granulocyte colony-stimulating factor (G-CSF) in breast cancer patients.

Methods: A total of 57 breast cancer patients were treated with docetaxel 120 mg/m(2). When the white blood cell (WBC) count decreased to 1.0x10(9)/L, patients were given G-CSF 5 mu g/kg daily by subcutaneous injection until the end of apheresis. Peripheral blood mononuclear cells (MNC) were isolated by Cobe Spectra Apheresis System. The percentage of CD34(+) cell was assayed by flow cytometry.

Results: At a median 6 of days (range 3-8) after the administration of docetaxel, the median WBC count decreased to 1.08x10(9)/L (range 0.20-2.31). The median duration of G-CSF mobilization was 3 days (range 2-7). The MNC collection was conducted 8-12 days (median 10 days) after docetaxel treatment. The median MNC was 5.35x10(8)/kg (range 0.59-14.07), the median CD34(+) cell count was 2.43x10(6)/kg (range 0.16-16.69). The CD34(+) cell count was higher than 1.00x10(6)/kg in 47 of 57 cases (82.46%) and higher than 2.00x10(6)/kg in 36 cases (63.16%). The CD34(+) cell count was higher than 2.00x10(6)/kg in 27 collections (23.68%). The MNC count and the CD34(+) cell count were correlated with the bottom of WBC after docetaxel chemotherapy (r=0.364, 0.502, P=0.005, 0.000). The CD34(+) cell count was correlated with the MNC count (r=0.597, P=0.000). The mobilization and apheresis were well tolerated in all patients. Mild perioral numbness and numbness of hand or feet were observed in 3 cases. No serious adverse events were reported.

Conclusion: Mobilization of peripheral blood hematopoietic stem cell by combining docetaxel with G-CSF was effective and safety in breast cancer patients.

语种英语
WOS记录号WOS:000290804200010
项目编号2007-2053
资助机构Beijing Capital Development Foundation for Medical Sciences
引用统计
被引频次:2[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67522
专题北京大学临床肿瘤学院
北京大学临床肿瘤学院_乳腺肿瘤内科
北京大学临床肿瘤学院_移植与免疫治疗病区
作者单位1.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst,Dept Breast Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China
2.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst,Dept Transfus, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China
推荐引用方式
GB/T 7714
Yu, Jing,Ren, Jun,Di, Li-jun,et al. Mobilization of Peripheral Blood Stem Cells Using Regimen Combining Docetaxel with Granulocyte Colony-stimulating Factor in Breast Cancer Patients[J]. CHINESE JOURNAL OF CANCER RESEARCH,2011,23(1):49-53.
APA Yu, Jing.,Ren, Jun.,Di, Li-jun.,Song, Guo-hong.,Zhu, Yu-lin.,...&Zhang, Chun-rong.(2011).Mobilization of Peripheral Blood Stem Cells Using Regimen Combining Docetaxel with Granulocyte Colony-stimulating Factor in Breast Cancer Patients.CHINESE JOURNAL OF CANCER RESEARCH,23(1),49-53.
MLA Yu, Jing,et al."Mobilization of Peripheral Blood Stem Cells Using Regimen Combining Docetaxel with Granulocyte Colony-stimulating Factor in Breast Cancer Patients".CHINESE JOURNAL OF CANCER RESEARCH 23.1(2011):49-53.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yu, Jing]的文章
[Ren, Jun]的文章
[Di, Li-jun]的文章
百度学术
百度学术中相似的文章
[Yu, Jing]的文章
[Ren, Jun]的文章
[Di, Li-jun]的文章
必应学术
必应学术中相似的文章
[Yu, Jing]的文章
[Ren, Jun]的文章
[Di, Li-jun]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。